CompoAtlas

Joint Pain Relief II

Natural health product licensed in Canada

Other names
Advanced Inflammation Relief, Anti-Inflammation, InflaMin, Inflammation Relief, Joint Pain Relief
Licence holder
Advanced Orthomolecular Research Inc.
NPN or DIN-HM
80067168
Status
Active licence
Licence date
25 February 2016
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Harpagophytum procumbens

Source : Racine(s) secondaire(s) tubérisée(s)

Extract : Matériel brut sec

Extraction ratio : 22.5:1

Dry plant equivalent : 1,125 milligramme

50 milligrammeNot calculated
Boswellia serrata

Source : Gum oleoresin

Potency : 40 Pour cent boswellic acids

333.33 milligrammeNot calculated
Acide hyaluronique

Source : Streptococcus equi - capsule extracellulaire bactérienne

40 milligrammeNot calculated
Acide hyaluronique

Source : Hyaluronate de sodium

40 milligrammeNot calculated
(1E,6E)-1,7-Bis(4-hydroxy-3-méthoxyphényl)-1,6-heptadiène-3,5-dione

Source : Curcumine

26.67 milligrammeNot calculated

Non-medicinal ingredients

Dioxyde de silicium, Palmitate d'ascorbyle, Cellulose microcristalline, Stéaryl fumarate de sodium, Hypromellose, Lécithine, Fécule de pomme de terre, Maltodextrine, Acide stéarique

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Capsule3 Tous les jours

Uses authorised in Canada

Helps to relieve joint pain and swelling associated with osteoarthritis of the knee. Helps support joint health. Used in Herbal Medicine to help relieve joint pain associated with osteoarthritis.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80067168

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Harpagophytum procumbens
    Read the warning, when it applies and the studies cited

    DEVIL'S CLAW - HARPAGOPHYTUM

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 27 March 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line